Sigma Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Sigma Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-416	Closed	-$44K	–	20
2018 Q1	$44K	Hold	416	–	–	0.04%	16
2017 Q4	$53K	Hold	416	–	–	0.04%	16
2017 Q3	$48K	Hold	416	–	–	0.04%	15
2017 Q2	$54K	Hold	416	–	–	0.05%	16
2017 Q1	$69K	Hold	416	–	–	0.06%	16
2016 Q4	$39K	Hold	416	–	–	0.03%	16
2016 Q3	$43K	Hold	416	–	–	0.04%	15
2016 Q2	$49K	Sell	416 -391	-48%	-$39.2K	0.04%	15
2016 Q1	$57K	Hold	807	–	–	0.05%	16
2015 Q4	$59K	Buy	807 +7	+0.9%	+$535	0.04%	26
2015 Q3	$63K	Hold	800	–	–	0.04%	27
2015 Q2	$63K	Hold	800	–	–	0.04%	28
2015 Q1	$62K	Hold	800	–	–	0.04%	29
2014 Q4	$80K	Hold	800	–	–	0.05%	29
2014 Q3	$79K	Hold	800	–	–	0.06%	27
2014 Q2	$119K	Hold	800	–	–	0.08%	28
2014 Q1	$137K	Hold	800	–	–	0.1%	29
2013 Q4	$121K	Hold	800	–	–	0.08%	26
2013 Q3	$176K	Hold	800	–	–	0.12%	25
2013 Q2	$90K	Buy	+800	New	+$91.4K	0.07%	26

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Sigma Investment Management's VBIV Position: Q2 2018 in Review

Sigma Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 416 shares — an estimated $44K sold.

Sigma Investment Management first reported a position in VBIV in Q2 2013 and held it in 20 quarters. The position peaked at $176K in Q3 2013. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

Sigma Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
Sigma Investment Management sold 416 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $44K.
Sigma Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2013 and held it in 20 quarters.
Sigma Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $176K in Q3 2013.
48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on Sigma Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.